TCL Archive Cancer Information Service facing $6 million cut, consolidation. Also Give NIH director greater authority, budget; review NCI’s special status, IOM says. August 1, 2003
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: Names Submitted For NIH Deputy Director; Gottesman Leads Genome Project Temporarily May 8, 1992
